Australia markets closed

Bio-Path Holdings, Inc. (BPTH)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
2.8100+0.0500 (+1.81%)
At close: 04:00PM EDT
2.7300 -0.08 (-2.85%)
After hours: 06:46PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 4.32M
Enterprise value 3.38M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)9.80
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.22

Trading information

Stock price history

Beta (5Y monthly) 0.45
52-week change 3-90.51%
S&P500 52-week change 326.43%
52-week high 344.8000
52-week low 32.3500
50-day moving average 34.0580
200-day moving average 38.2815

Share statistics

Avg vol (3-month) 31.47M
Avg vol (10-day) 3136.47k
Shares outstanding 51.57M
Implied shares outstanding 61.57M
Float 8677.85k
% held by insiders 10.11%
% held by institutions 11.80%
Shares short (15 Apr 2024) 427.36k
Short ratio (15 Apr 2024) 40.8
Short % of float (15 Apr 2024) 43.64%
Short % of shares outstanding (15 Apr 2024) 43.63%
Shares short (prior month 15 Mar 2024) 463.35k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 318 Jan 2019
Ex-dividend date 4N/A
Last split factor 21:20
Last split date 323 Feb 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-103.19%
Return on equity (ttm)-220.02%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -15.76M
Net income avi to common (ttm)-16.08M
Diluted EPS (ttm)-33.6300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.05M
Total cash per share (mrq)1.55
Total debt (mrq)113k
Total debt/equity (mrq)25.62%
Current ratio (mrq)1.60
Book value per share (mrq)0.71

Cash flow statement

Operating cash flow (ttm)-11.54M
Levered free cash flow (ttm)-5.52M